Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-1991 | 06-1991 | 03-1991 | 12-1990 | 09-1990 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 534 | 710 | 839 | N/A | 118 |
| Marketable Securities | 0 | 0 | 0 | 10 | 0 |
| Receivables | 49 | 46 | 53 | 20 | 17 |
| Inventories | 8 | 13 | 15 | 30 | 52 |
| Other current assets | 1 | 2 | 3 | -10 | 9 |
| TOTAL | $590 | $770 | $909 | $50 | $196 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 11 | 11 | 11 | 4 | 4 |
| TOTAL | $11 | $11 | $11 | $4 | $4 |
| Total Assets | $733 | $858 | $1,005 | $140 | $297 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 204 | 178 | 102 | 0 | 75 |
| Accrued Expenses | 6 | 6 | 6 | 6 | 6 |
| Other current liabilities | 60 | 30 | 60 | N/A | 60 |
| TOTAL | $270 | $214 | $167 | $200 | $141 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| TOTAL | $1,500 | $1,500 | $1,500 | $1,500 | $1,500 |
| Total Liabilities | $1,770 | $1,714 | $1,667 | $1,700 | $1,641 |
| Shareholders' Equity | |||||
| Common Shares | 117 | 117 | 117 | 70 | 70 |
| Retained earnings | -17,547 | -17,362 | -17,104 | -16,880 | -16,619 |
| Other shareholders' equity | 543 | 535 | 546 | 10 | 526 |
| TOTAL | $-1,037 | $-856 | $-663 | $-2,080 | $-1,344 |
| Total Liabilities And Equity | $733 | $858 | $1,005 | $-380 | $297 |